CSRT.L Regulatory News (CSRT)

(a) Full name of discloser:

Jonathan Glenn

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Consort Medical PLC (offeror)

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Person acting in concert with the offeror

(e) Date dealing undertaken:

9 July 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

Class of relevant security:

Ordinary shares of 10 pence each

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

165,354*

0.335

Nil

Nil

(2) Cash-settled derivatives:

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

TOTAL:

165,354

0.335

Nil

Nil

Class of relevant security in relation to which subscription right exists:

Ordinary shares of 10 pence each

Details, including nature of the rights concerned and relevant percentages:

Interests in awards of ordinary shares of 10 pence each under the Performance Share Plan (PSP), Deferred Bonus Plan (DBP) and Save As You Earn (SAYE) plan of Consort Medical plc

Director

Scheme

No. of Ordinary Shares

Vesting Dates

% of total issued share capital of Consort Medical plc

Jonathan Glenn

PSP

182,580

June 2018, June 2019, June 2020 and June 2021

0.370

Jonathan Glenn

DBP

49,957

June 2019, June 2020 and June 2021

0.101

Jonathan Glenn

SAYE

1,853

September 2018 and September 2020

0.004

Class of relevant security

Purchase/sale

Number of securities

Price per unit

N/A

N/A

N/A

N/A

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

N/A

N/A

N/A

N/A

N/A

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Ordinary shares of 10 pence each

Acquisition of shares under the Share Incentive Plan of Consort Medical plc (the SIP)

Acquisition of 13 ordinary shares by the SIP Trustee pursuant to the SIP

£11.76

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

12 July 2018

Michelle Palmer

Telephone number:

+44 (0) 1442 867 920